Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial.
Daniel D'Almeida PretoMariana Toledo BastonCamilla Centurion GeraigeSarah Bertazzi AugustoMarco Antonio de OliveiraAugusto Elias MamereGustavo Dix Junqueira PintoJosiane Mourão DiasPedro Rafael Martins De MarchiBianca Sakamoto Ribeiro PaivaCarlos Eduardo PaivaPublished in: BMC cancer (2019)
This Trial was registered on March 19, 2018 with ClinicalTrials.gov , NCT03469063. Protocol version: 2.0 from March 26, 2018. Trial status: Patient enrollment in the study began in April, 2018.